Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.47 |
| ▸ | FDFT1 | P37268 | 2/20 | 0.45 |
| ▸ | CNR1 | P21554 | 5/20 | 0.42 |
| ▸ | CNR2 | P34972 | 3/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | AKT1 | P31749 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.38 |
| ▸ | SCN10A | Q9Y5Y9 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8621289 | 1.00 | SLC6A2 (0.56) | SLC6A2SLC6A3SLC6A4ADRB2FDFT1 | |
| SCHEMBL4691720 | 0.95 | SLC6A3 (0.62) | SLC6A2SLC6A3SLC6A4ADRB2FDFT1 | |
| SCHEMBL8623070 | 0.94 | FDFT1 (0.53) | SLC6A2SLC6A3SLC6A4ADRB2FDFT1 | |
| SCHEMBL8623834 | 0.94 | FDFT1 (0.53) | SLC6A2SLC6A3SLC6A4ADRB2FDFT1 | |
| SCHEMBL8620804 | 0.94 | FDFT1 (0.53) | SLC6A2SLC6A3SLC6A4ADRB2FDFT1 | |
| SCHEMBL8625643 | 0.94 | FDFT1 (0.53) | SLC6A2SLC6A3SLC6A4ADRB2FDFT1 | |
| Hydrochloric Acid SCHEMBL3371509 | 0.93 | SLC6A2 (0.60) | SLC6A2SLC6A3SLC6A4ADRB2FDFT1 | |
| Hydrochloric Acid SCHEMBL7761818 | 0.92 | FDFT1 (0.52) | SLC6A2SLC6A3SLC6A4ADRB2FDFT1 | |
| SCHEMBL8622323 | 0.89 | TAAR1 (0.53) | SLC6A2SLC6A3FDFT1CNR1CNR2 | |
| SCHEMBL8622953 | 0.88 | SLC6A3 (0.55) | SLC6A2SLC6A3SLC6A4ADRB2FDFT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5777150-A | Substituted amic acid derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-07-07 | — | — | US | disclosed |
| EP-0611749-B1 | Substituted amic acid derivatives useful for treatment of arteriosclerosis | BANYU PHARMA CO LTD (JP) | 1997-10-22 | — | — | EP | disclosed |
| US-5616803-A | EXHIBIT SQUALENE SYNTHASE-INHIBITORY ACTIVITIES; USEFUL IN TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA, HYPERLIPEMIA AND ARTERIOSCLEROSIS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1997-04-01 | — | — | US | disclosed |
| US-5606101-A | INTERMEDIATES FOR SQUALENE SYNTHASE INHIBITORS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1997-02-25 | — | — | US | disclosed |
| US-5488149-A | SQUALENE SYNTHASE INHIBITORS AS ANTICHOLESTEROL OR ANTILIPEMIC AGENTS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1996-01-30 | — | — | US | disclosed |
| EP-0611749-A1 | Substituted amic acid derivatives useful for treatment of arteriosclerosis | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1994-08-24 | — | — | EP | disclosed |